MedPath

Efficacy of a Dietary Supplement on Parameters of Skin Aging in Men and Women

Not Applicable
Completed
Conditions
Skin Aging
Interventions
Dietary Supplement: HyaCera™
Dietary Supplement: Placebo
Registration Number
NCT06083402
Lead Sponsor
Natals, Inc. dba Ritual
Brief Summary

As the body ages, the skin experiences natural changes in structure and composition. These changes may manifest visibly as increased skin dryness, wrinkling, and a loss of firmness/elasticity. In this double-blind, randomized, placebo-controlled trial, the investigators will recruit healthy men and women with mild to moderate signs of skin aging and randomly assign them to either receive a HyaCera™ or placebo for 12 weeks. The investigators will perform a series of objective and subjective measurements to assess changes in skin condition. The investigators hypothesize that consumption of HyaCera™ leads to improvements in the general condition of the skin including skin hydration, crow's feet wrinkling, and other skin aging parameters.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
63
Inclusion Criteria
  • Healthy male and female volunteers, 25 - 70 years old with mild to moderate fine lines and wrinkles
  • All ethnicities and skin types
  • Willing to maintain current skincare regimen on face, arms, and legs and withhold all facial and body treatments throughout the course of the study
Exclusion Criteria
  • Self-reported pregnant or breastfeeding or planning to become pregnant during the course of the study
  • Any conditions on the face, arms and legs that would interfere with evaluations
  • Under treatment for any known health issues/medical conditions including chronic health conditions and skin diseases/conditions

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ActiveHyaCera™Participants receive 1 HyaCera™ capsule orally once daily for 12 weeks
PlaceboPlaceboParticipants receive 1 placebo capsule orally once daily for 12 weeks
Primary Outcome Measures
NameTimeMethod
Crow's Feet Wrinklesat week 0, Week 4, Week 8, and Week 12

Degree of crow's feet wrinkling will be measured via Visioscan®

Skin Smoothnessat week 0, Week 4, Week 8, and Week 12

Skin smoothness will be measured via Visioscan®

Skin Hydrationat week 0, Week 4, Week 8, and Week 12

Skin surface hydration will be measured via Corneometer® 825

Secondary Outcome Measures
NameTimeMethod
Skin Elasticityat week 0, Week 4, Week 8, and Week 12

Skin elasticity will be measured via Cutometer® MPA 580

Skin Scalinessat week 0, Week 4, Week 8, and Week 12

Skin scaliness will be measured via Visioscan®

Skin Barrier Functionat week 0, Week 4, Week 8, and Week 12

Skin barrier function (as transepidermal water loss) will be measured via Tewameter®

Trial Locations

Locations (1)

Princeton Consumer Research

🇺🇸

Raritan, New Jersey, United States

© Copyright 2025. All Rights Reserved by MedPath